Cantor Fitzgerald Downgrades Cell Genesys (CEGE) to Hold, Drops Price Target to $2
Tweet Send to a Friend
Cantor Fitzgerald downgrades Cell Genesys (Nasdaq: CEGE) from Buy to Hold. Price target lowered to $2.
Cantor analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cantor analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
